Ikena Oncology appoints Owen Hughes as Board Chair; Ron Renaud resigns

ImageneBio, Inc.

Owen Hughes appointed to Board and as Chairman, effective Dec 15, 2022; fills vacancy from board expansion then reduction.
Ron Renaud resigned as Chairman and Board member to focus on role as Managing Director at Bain Capital Life Sciences; no dispute.
Hughes also named Chair of Audit Committee and member of Compensation Committee; designated audit committee financial expert.
Hughes is CEO of Sail Bio and Co-Founder of Cullinan Oncology; brings public company board experience.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ronald Renaud

Chairman of the Board

IMA · ImageneBio, Inc.

Effective: 2022-12-15
Successor: Owen Hughes
Filed: December 19, 2022, 6:59 PM ET

On December 15, 2022, Ronald Renaud notified the Company of his intent to resign from the Company’s Board and from his positions as Chairman of the Board, Chair of the Audit Committee of the Board and member of the Compensation Committee of the Board, effective December 15, 2022.

Appointed

Owen Hughes

Chairman of the Board

IMA · ImageneBio, Inc.

Effective: 2022-12-15
Filed: December 19, 2022, 6:59 PM ET

On December 15, 2022, Mr. Hughes filled the vacated positions on the committees of the Board and became the Chairman of the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ronald Renaud resigned as Chairman of the Board at ImageneBio, Inc..

Action: resigned
Role: Chairman of the Board

Exact text from the filing

On December 15, 2022, Ronald Renaud notified the Company of his intent to resign from the Company’s Board and from his positions as Chairman of the Board, Chair of the Audit Committee of the Board and member of the Compensation Committee of the Board, effective December 15, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Owen Hughes was appointed as Chairman of the Board at ImageneBio, Inc..

Action: appointed
Role: Chairman of the Board

Exact text from the filing

On December 15, 2022, Mr. Hughes filled the vacated positions on the committees of the Board and became the Chairman of the Board

View on SEC.gov

ImageneBio, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-308371

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.